Sep 27, 2018 | News, September Newsletter
VIDEO: Cross-training tomorrow’s scientists “CLP is the mothership for bringing the chemist and the biologist and engineers together.” – Rick Silverman, Patrick G. Ryan/Aon Professor, inventor of the blockbuster drug Lyrica® Solving the most pressing problems in human...
Sep 26, 2018 | Gallery, News, September Newsletter
When Patrick Martin, Managing Director, Martin Investment Management, LLC, first heard about the idea to form a new institute at Northwestern University that would combine the strengths of different fields of study into one effort focused on finding new drugs and...
Sep 26, 2018 | Gallery, News, September Newsletter
One of the most intractable obstacles in treating and curing cancer is the tumor’s ability to adapt to and resist treatments. Although many new and effective drugs are available, according to the National Cancer Institute, “nearly all current treatments face the same...
Sep 26, 2018 | Gallery, News, September Newsletter
When it comes to fighting drug resistance and other emergent health threats like Ebola, AIDS, H1N1, SARS, time is of the essence. “It’s amazing to think that by 2050, antibiotic resistance will threaten 10 million lives per year which is more than cancer kills today.”...
Sep 24, 2018 | News, September Newsletter
This year, two leaders in pharmaceuticals and bioscience, respectively, have joined the Chemistry of Life Processes Institute’s Executive Advisory Board. The newest members of the board are Sheila Westmoreland, DPM, MPH, PMP, senior director, Gene Therapy, Sarepta...
Jul 30, 2018 | Impact, News, September Newsletter
DNA sequencing used to cost thousands of dollars. Now, you can pay $99 for a genetic screening, all without leaving your house. “The genome was a wild frontier in the 90s, but ten years later, it wasn’t,” says molecular biosciences professor and Chemistry of Life...
